On April 10, 2018, the Danish Medicine Verification System received formal approval from the European Medicines Verification Organization (EMVO) that the system can be connected to the production environment.
After reaching this milestone, the Danish Medicine Verification Organization (DMVO) can begin its pilot on Monday, with the implementation of the IT system to support the EU Directive 2011/62/EU on Falsified Medicines.
Together with Slovenia, Ireland and Sweden, Denmark is among the first four countries to receive production approval. Per the organization’s announcement, “DMVO could not have reached this milestone without active support from the many stakeholders involved and without close cooperation with the other countries with the same blueprint provider.”
